▟ Vinebot intrinsic value, daily

← back

UHS Universal Health Services

healthcare · valued with opus medium conviction · deep-dived 2026-11-17

STRONG BUY
Intrinsic value$340.62
Price (at call)$197.80
Margin of safety +72.2%
vs market (rating basis) +136.0%

Steady hospital and behavioral franchise priced for a policy cliff its margins can mostly absorb.

The story

UHS runs two franchises: acute-care hospitals in fast-growing Sun Belt markets and the largest US behavioral health network, where scarce licensed beds and certificate-of-need barriers protect pricing. It is a mature, cash-generative business growing mid-single digits, with margins lifted by labor normalization and state supplemental payments. The main threat is Medicaid policy (phase-down of state-directed payments and provider taxes from 2028), not competitive erosion.

No material facts changed: TTM revenue grew about 6% and TTM margin of 11.5% matches my prior target, which sits below the 12.2% FY peak to absorb supplemental-payment cuts and payer-mix pressure. Sales-to-capital nudges from 1.48 to 1.50 to reflect TTM 1.53, and a 7-year horizon fits a mature hospital operator.

Value drivers

Revenue growth (Y1)6.0%
Terminal growth2.5%
Forecast horizon7y
Target operating margin11.5%
Years to target margin3
Sales-to-capital1.50
Beta1.00
Failure probability1.0%
Cost of capital (WACC)8.3%
Terminal WACC8.3%

Valuation bridge

PV of explicit FCFF6.84B
PV of terminal value17.75B
Equity value19.64B
÷ shares → per share$340.62

Projected free cash flow to the firm

YrRevenueGrowthMarginNOPATReinvestFCFFPV
1 19.45B 6.0% 11.5% 1.72B 734.10M 982.59M 907.15M
2 20.51B 5.4% 11.5% 1.81B 702.50M 1.11B 942.61M
3 21.50B 4.8% 11.5% 1.89B 660.80M 1.23B 970.78M
4 22.41B 4.2% 11.5% 1.97B 609.13M 1.37B 992.28M
5 23.23B 3.7% 11.5% 2.05B 547.86M 1.50B 1.01B
6 23.95B 3.1% 11.5% 2.11B 477.59M 1.63B 1.01B
7 24.55B 2.5% 11.5% 2.16B 399.18M 1.76B 1.01B

Key risks

  • Medicaid supplemental payment and provider-tax phase-downs cut high-margin revenue from 2028
  • Exchange subsidy expiry raises uninsured volume and bad debt
  • Labor cost reinflation and behavioral-health litigation verdicts

Catalysts

  • Continued buybacks at a low EBIT multiple shrink share count
  • Behavioral volume recovery and new acute capacity (DC, Florida) ramping to mature margins

History

DatePriceIntrinsicMoSRating
2026-11-17$197.80 $340.62 +72.2% STRONG BUY
2026-09-28$178.86 $332.33 +85.8% STRONG BUY
2026-08-07$169.72 $374.62 +120.7% STRONG BUY
2026-06-23$145.85 $379.02 +159.9% STRONG BUY